Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch)

Mechanisms of Development

Volumn 69, Issue 1-2, 1997, Pages 39-51

  Henderson, Deborah J ^a   Ybot Gonzalez, Patricia ^a   Copp, Andrew J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Mutant mouse; Neural crest abnormality; Over expression

Indexed keywords

PROTEOCHONDROITIN SULFATE; VERSICAN;

ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONGENITAL MALFORMATION; EMBRYO; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HETEROZYGOTE; HOMOZYGOTE; MESENCHYME; MOUSE; NEURAL CREST; NEURAL TUBE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CADHERINS; CELL MOVEMENT; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HOMOZYGOTE; IN SITU HYBRIDIZATION; LECTINS, C-TYPE; MALE; MESODERM; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; NEURAL CREST; PAIRED BOX TRANSCRIPTION FACTORS; PROTEOCHONDROITIN SULFATES; TRANSCRIPTION FACTORS; VERSICANS;

ANIMALIA;

EID: 0031415403     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(97)00151-2     Document Type: Article

References (50)

1. Auerbach R. Analysis of the developmental effects of a lethal mutation in the house mouse. J. Exp. Zool. 127:1954;305-329.
2. Beechey C.V., Searle A.G. Mutations at the Sp locus. Mouse News Lett. 75:1986;28.
3. Bober E., Franz T., Arnold H.-H., Gruss P., Tremblay P. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development. 120:1994;603-612.
4. Chalepakis G., Stoykova A., Wijnholds J., Tremblay P., Gruss P. Pax: gene regulators in the developing nervous system. J. Neurobiol. 24:1993;1367-1384.
5. Chalepakis G., Jones F.S., Edelman G.M., Gruss P. Pax-3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. USA. 91:1994;12745-12749.
6. 2H) mutant. Development 124, 505-514.
7. Conway, S.J., Henderson, D.J., Anderson, R.H., Kirby, M.L., Copp, A.J., 1997b. Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc. Res., in press.
8. Daston G., Lamar E., Olivier M., Goulding M. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development. 122:1996;1017-1027.
9. Doege K., Sasaki M., Horigan E., Hassell J.R., Yamada Y. Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. J. Biol. Chem. 262:1987;17757-17767.
10. Domowicz M., Li H., Hennig A., Henry J., Vertel B.M., Schwartz N.B. The biochemically and immunologically distinct CSPG of notochord is a product of the aggrecan gene. Dev. Biol. 171:1995;655-664.
11. Edelman G.M., Jones F.S. Developmental control of N-CAM expression by Hox and Pax gene products. Phil. Trans. R. Soc. Lond. (Biol.). 349:1995;305-312.
12. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell. 67:1991;767-774.
13. Erickson, C.A., 1988. Control of pathfinding by the avian trunk neural crest. Development 103 (Suppl.), 63-80.
14. Franz T., Kothary R., Surani M.A.H., Halata Z., Grim M. The Splotch mutation interferes with muscle development in the limbs. Anat. Embryol. 187:1993;153-160.
15. Goulding M., Lumsden A., Paquette A.J. Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development. 120:1994;957-971.
16. Goulding M.D., Chalepakis G., Deutsch U., Erselius J.R., Gruss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10:1991;1135-1147.
17. Horstadius, S., 1950. The Neural Crest. Its Properties and Derivatives in the Light of Experimental Research. Oxford University Press, New York.
18. Inoue T., Chisaka O., Matsunami H., Takeichi M. Cadherin-6 expression transiently delineates specific rhombomeres, other neural tube subdivisions, and neural crest subpopulations in mouse embryos. Dev. Biol. 183:1997;183-194.
19. Ito K., Shinomura T., Zako M., Ujita M., Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulphate proteoglycan generated by alternative splicing. J. Biol. Chem. 270:1995;958-965.
20. Kawasaki, E.S., 1990. PCR Protocols: A Guide to Methods and Applications. Academic Press, New York.
21. Keynes R.J., Stern C.D. Segmentation in the vertebrate nervous system. Nature. 310:1984;413-429.
22. Krotoski D.M., Domingo C., Bronner-Fraser M. Distribution of a putative cell surface receptor for fibronectin and laminin in the avian embryo. J. Cell Biol. 103:1986;1061-1071.
23. Landolt R.M., Vaughan L., Winterhalter K.H., Zimmermann D.R. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development. 121:1995;2303-2312.
24. Le Douarin, N.M., 1982. The Neural Crest. Cambridge University Press, Cambridge.
25. Maroto M., Reshef R., Münsterberg A.E., Koester S., Goulding M., Lassar A.B. Ectopic Pax-3 activates Myo-D and Myf-5 expression in embryonic mesoderm and neural tissue. Cell. 89:1997;139-148.
26. d mouse neural tube explants. Teratology. 42:1990;171-182.
27. Newgreen D., Thiery J.P. Fibronectin in early avian embryos: synthesis and distribution along the migration pathways of neural crest cells. Cell Tissue Res. 211:1980;269-291.
28. Newgreen D.F., Scheel M., Kastner V. Morphogenesis of sclerotome and neural crest in avian embryos. In vivo and in vitro studies on the role of notochordal extracellular material. Cell Tissue Res. 244:1986;299-313.
29. Perris R., Perissinotto D., Pettway Z., Bronner-Fraser M., Mörgelin M., Kimata K. Inhibitory effects of PG-H/aggrecan and PG-M/versican on avian neural crest cell migration. FASEB J. 10:1996;293-301.
30. Perris R. The extracellular matrix in neural crest-cell migration. Trends Neurosci. 20:1997;23-31.
31. Perris R., Johansson S. Amphibian neural crest cell migration on purified extracellular matrix components: a chondroitin sulphate proteoglycan inhibits locomotion on fibronectin substrates. J. Cell Biol. 105:1987;2511-2521.
32. Pettway Z., Guillory G., Bronner-Fraser M. Absence of neural crest cells from the region surrounding implanted notochords in situ. Dev. Biol. 142:1990;335-345.
33. Pettway Z., Domowicz M., Schwartz N.B., Bronner-Fraser M. Age-dependent inhibition of neural crest migration by the notochord correlates with alterations in the S103L chondroitin sulfate proteoglycan. Exp. Cell Res. 225:1996;195-206.
34. Ranscht B., Bronner-Fraser M. T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo. Development. 111:1991;15-22.
35. Rauch U., Karthikeyan L., Maurel P., Margolis R.U., Margolis R.K. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 267:1992;19536-19547.
36. Ring C., Hassell H., Halfter W. Expression pattern of collagen IX and potential role in the segmentation of the peripheral nervous system. Dev. Biol. 180:1996;41-53.
37. Serbedzija G.N., Fraser S., Bronner-Fraser M. Pathways of trunk neural crest cell migration in the mouse embryo as revealed by vital dye labelling. Development. 108:1990;605-612.
38. Serbedzija G.N., Bronner-Fraser M., Fraser S.E. Developmental potential of trunk neural crest cells in the mouse. Development. 120:1994;1709-1718.
39. Serbedzija G.N., McMahon A.P. Analysis of neural crest cell migration in splotch mice using a neural crest-specific LacZ reporter. Dev. Biol. 185:1997;139-147.
40. Tajbakhsh S., Rocancourt D., Cossu G., Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell. 89:1997;127-138.
41. Tan S., Crossin K.L., Hoffman S., Edelman G.M. Asymmetric expression in somites of cytotactin and its proteoglycan ligand is correlated with neural crest cell distribution. Proc. Natl. Acad. Sci. USA. 84:1987;7977-7981.
42. Tennyson V.M., Payette R.F., Rothman T.P., Gershon M.D. Distribution of hyaluronic acid and chondroitin sulfate proteoglycans in the presumptive aganglionic terminal bowel of ls/ls fetal mice: an ultrastructural analysis. J. Comp. Neurol. 291:1990;345-362.
43. Trasler D.G., Morriss-Kay G. Immunohistochemical localization of chondroitin and heparan sulfate proteoglycans in pre-spina bifida splotch mouse embryos. Teratology. 44:1991;571-579.
44. Wang H.U., Anderson D.J. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron. 18:1997;383-396.
45. Watanabe, H., Kimata, K., Line, S., Strong, D., Gao, L., Kozak, C.A., Yamada, Y., 1994. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat. Genet. 7, 154-157.
46. Weston J.A. The migration and differentiation of neural crest cells. Adv. Morphog. 8:1970;41-114.
47. Wilkinson, D.G., 1992. In Situ Hybridisation: A Practical Approach. IRL Press, Oxford.
48. Yamada H., Watanabe K., Shimonaka M., Yamaguchi Y. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem. 269:1994;10119-10126.
49. Yang X.-M., Vogan K., Gros P., Park M. Expression of the met receptor tyrosine kinase in muscle progenitor cells in somites and limbs is absent in Splotch mice. Development. 122:1996;2163-2171.
50. Zimmermann D.R., Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 8:1989;2975-2981.